Keros Therapeutics to Present at the Virtual 25th Annual Congress of the European Hematology Association
LEXINGTON, Mass., May 14, 2020 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on […]